MicroRNA-27a indirectly regulates estrogen receptor α expression and hormone responsiveness in MCF-7 breast cancer cells

Endocrinology

Volumn 151, Issue 6, 2010, Pages 2462-2473

  Li, Xiangrong ^a   Mertens Talcott, Susanne U ^a   Zhang, Shu ^b   Kim, KyoungHyun ^b   Ball, Judith ^a   Safe, Stephen ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; MICRORNA; OLIGONUCLEOTIDE; SP1 PROTEIN; SP3 PROTEIN; SP4 PROTEIN; UNCLASSIFIED DRUG; MIRN27 MICRORNA, HUMAN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP2; TRANSCRIPTION FACTOR SP4;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL LYSATE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GC RICH SEQUENCE; GENE OVEREXPRESSION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; RNA INTERFERENCE; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECT; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR; SP2 TRANSCRIPTION FACTOR; SP4 TRANSCRIPTION FACTOR;

EID: 77954497664     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1150     Document Type: Article

References (46)

1. Hall JM, Couse JF, Korach KS 2001 The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872
2. Olefsky JM 2001 Nuclear receptor minireview series. J Biol Chem 276:36863-36864
3. Nilsson S, Gustafsson JA 2002 Biological role of estrogen and estrogen receptors. Crit Rev Biochem Mol Biol 37:1-28
4. O'Malley BW 2005 A life-long search for the molecular pathways of steroid hormone action. Mol Endocrinol 19:1402-1411
5. Matthews J, Gustafsson JA 2003 Estrogen signaling: a subtle balance between ERα and ERβ. Mol Interv 3:281-292
6. Levenson AS, Jordan VC 1997 MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res 57:3071-3078
7. Coser KR, Chesnes J, Hur J, Ray S, Isselbacher KJ, Shioda T 2003 Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray. Proc Natl Acad Sci USA 100:13994-13999
8. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574
9. Klein-Hitpass L, Schorpp M, Wagner U, Ryffel GU 1986 An estrogen-responsive element derived from the 5′-flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46:1053-1061
10. Hyder SM, Chiappetta C, Stancel GM 1999 Interaction of human estrogen receptors γ and β with the same naturally occurring estrogen response elements. Biochem Pharmacol 57:597-601
11. Safe S, Kim K 2004 Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acids Res Mol Biol 77:1-36
12. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson JA, Safe S 2000 Ligand-, cell- and estrogen receptor subtype (α/β)- dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379-5387
13. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P 2000 Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317
14. Delfino F, Walker WH 1999 Hormonal regulation of the NF-κB signaling pathway. Mol Cell Endocrinol 157:1-9
15. Blobel GA, Orkin SH 1996 Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol Cell Biol 16:1687-1694
16. Adams BD, Furneaux H, White BA 2007 The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21:1132-1147
17. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ 2008 MicroRNA-221/222 negatively regulates estrogen receptor α and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283:31079-31086
18. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S 2007 The oncogenic microRNA-27a targets genes that regulate specificity protein (Sp) transcription factors and the G2-M checkpoint in MDAMB-231 breast cancer cells. Cancer Res 67:11001-11011
19. Tillotson LG 1999 RIN ZF, a novel zinc finger gene, encodes proteins that bind to the CACC element of the gastrin promoter. J Biol Chem 274:8123-8128
20. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC 2006 Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 66:1277-1281
21. deGraffenried LA, Hilsenbeck SG, Fuqua SA 2002 Sp1 is essential for estrogen receptor α gene transcription. J Steroid Biochem Mol Biol 82:7-18
22. deGraffenried LA, Hopp TA, Valente AJ, Clark RA, Fuqua SA 2004 Regulation of the estrogen receptor α minimal promoter by Sp1, USF-1 and ERα. Breast Cancer Res Treat 85:111-120
23. Khan S, Wu F, Liu S, Wu Q, Safe S 2007 Role of specificity protein (Sp) transcription factors in estrogen-induced gene expression in MCF-7 breast cancer cells. J Mol Endocrinol 39:289-304
24. Khan S, Abdelrahim M, Samudio I, Safe S 2003 Estrogen receptor/ Sp1 complexes are required for induction of cad gene expression by 17β-estradiol in breast cancer cells. Endocrinology 144:2325-2335
25. Bouwman P, Philipsen S 2002 Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 195:27-38
26. Black AR, Black JD, Azizkhan-Clifford J 2001 Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188:143-160
27. Dynan WS, Tjian R 1983 The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35:79-87
28. Marin M, Karis A, Visser P, Grosveld F, Philipsen S 1997 Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 89:619-628
29. Safe S, Abdelrahim M 2005 Sp transcription factor family and its role in cancer. Eur J Cancer 41:2438-2448
30. Oh JE, Han JA, Hwang ES 2007 Downregulation of transcription factor, Sp1, during cellular senescence. Biochem Biophys Res Commun 353:86-91
31. Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, Yao J, Ajani J, Xie K 2003 Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9:6371-6380
32. Yao JC, Wang L, Wei D, Gong W, Hassan M, Wu TT, Mansfield P, Ajani J, Xie K 2004 Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 10:4109-4117
33. Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, Tang H, Xiong Q, Wang B, Li XC, Xie K 2001 Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 61:4143-4154
34. Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M 2000 Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 60:1546-1551
35. Chiefari E, Brunetti A, Arturi F, Bidart JM, Russo D, Schlumberger M, Filetti S 2002 Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation? BMC Cancer 2:35
36. Lou Z, O'Reilly S, Liang H, Maher VM, Sleight SD, McCormick JJ 2005 Down-regulation of overexpressed Sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res 65:1007-1017
37. Abdelrahim M, Smith 3rd R, Burghardt R, Safe S 2004 Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res 64:6740-6749
38. Abdelrahim M, Baker CH, Abbruzzese JL, Sheikh-Hamad D, Liu S, Cho SD, Yoon K, Safe S 2007 Regulation of vascular endothelial growth factor receptor-1 (VEGFR1) expression by specificity proteins 1, 3 and 4 in pancreatic cancer cells. Cancer Res 67:3286-3294
39. Chintharlapalli S, Papineni S, Ramaiah SK, Safe S 2007 Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res 67:2816-2823
40. Abdelrahim M, Baker CH, Abbruzzese JL, Safe S 2006 Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation. J Natl Cancer Inst 98:855-868
41. Higgins KJ, Abdelrahim M, Liu S, Yoon K, Safe S 2006 Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins. Biochem Biophys Res Commun 345:292-301
42. Finkenzeller G, Sparacio A, Technau A, Marmé D, Siemeister G 1997 Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for plateletderived growth factor-induced gene expression. Oncogene 15:669-676
43. Li Y, Xie M, Yang J, Yang D, Deng R, Wan Y, Yan B 2006 The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter. Oncogene 25:3296-3306
44. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R 2008 Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7:464-473
45. Han X, Guo J, Deng W, Zhang C, Du P, Shi T, Ma D 2008 Highthroughput cell-based screening reveals a role for ZNF131 as a repressor of ERα signaling. BMC Genomics 9:476
46. Velarde MC, Zeng Z, McQuown JR, Simmen FA, Simmen RC 2007 Krüppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor α signaling in Ishikawa endometrial adenocarcinoma cells. Mol Endocrinol 21:2988-3001